GNL3L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.719800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.076800E-01
Normal-vs-Stage2
5.228400E-01
Normal-vs-Stage3
8.424100E-02
Normal-vs-Stage4
9.158600E-01
Stage1-vs-Stage2
9.021200E-01
Stage1-vs-Stage3
4.403700E-03
Stage1-vs-Stage4
5.642000E-01
Stage2-vs-Stage3
5.389800E-02
Stage2-vs-Stage4
3.394200E-01
Stage3-vs-Stage4
1.265830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.381000E-01
Normal-vs-AfricanAmerican
8.047400E-01
Normal-vs-Asian
2.781600E-01
Caucasian-vs-AfricanAmerican
1.078580E-01
Caucasian-vs-Asian
4.202800E-01
AfricanAmerican-vs-Asian
1.020820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.828600E-01
Normal-vs-Female
4.769400E-01
Male-vs-Female
8.634600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.275800E-01
Normal-vs-Age(41-60Yrs)
7.611400E-01
Normal-vs-Age(61-80Yrs)
3.879200E-01
Normal-vs-Age(81-100Yrs)
1.919030E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.658800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.402800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.284000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.352400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.179790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.578800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.975200E-01
Normal-vs-Daily Drinker
2.842800E-01
Normal-vs-Weekly Drinker
3.920600E-01
Normal-vs-Occasional Drinker
5.728000E-01
Normal-vs-Social Drinker
6.390400E-01
Non Drinker-vs-Daily Drinker
6.223800E-01
Non Drinker-vs-Weekly Drinker
7.099800E-01
Non Drinker-vs-Occasional Drinker
3.138600E-01
Non Drinker-vs-Social Drinker
2.439400E-01
Daily Drinker-vs-Weekly Drinker
4.736600E-01
Daily Drinker-vs-Occasional Drinker
2.000200E-01
Daily Drinker-vs-Social Drinker
1.645770E-01
Weekly Drinker-vs-Occasional Drinker
5.893200E-01
Weekly Drinker-vs-Social Drinker
4.725600E-01
Occasional Drinker-vs-Social Drinker
8.449400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.347400E-01
Normal-vs-Grade 2
2.415800E-01
Normal-vs-Grade 3
1.758370E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.411450E-01
Grade 1-vs-Grade 3
7.346100E-02
Grade 1-vs-Grade 4
5.347400E-01
Grade 2-vs-Grade 3
5.315800E-01
Grade 2-vs-Grade 4
2.415800E-01
Grade 3-vs-Grade 4
1.758370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.937800E-01
Normal-vs-NonDiabetic
3.612400E-01
Diabetic-vs-NonDiabetic
6.156600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.514800E-01
Normal-vs-NoPancreatitis
3.732200E-01
Pancreatitis-vs-NoPancreatitis
8.334800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.557400E-01
Normal-vs-N1
5.552800E-01
N0-vs-N1
2.639800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.822800E-01
Normal-vs-TP53-NonMutant
6.587600E-01
TP53-Mutant-vs-TP53-NonMutant
3.002800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
